2.19

2.19 (-0.04%)

As of Aug 05, 2022

Entasis Therapeutics Holdings Inc. [ETTX]

Source: 

Company Overview

We are an advanced, late clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted antibacterial products that address high unmet medical needs to treat serious infections caused by multidrug-resistant pathogens.

CountryUS
Headquarterswalthammassachusetts
Phone Number(781) 810-0120
Industrypharmaceutical preparations
CEOManoussos Perros
Websiteentasistx.com

Recent Stories